438 related articles for article (PubMed ID: 12239227)
1. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study.
Farrell DJ; Morrissey I; Bakker S; Felmingham D
J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():39-47. PubMed ID: 12239227
[TBL] [Abstract][Full Text] [Related]
2. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
3. Streptococcus pneumoniae and Streptococcus pyogenes isolated from a paediatric population in Great Britain and Ireland: the in vitro activity of telithromcycin versus comparators.
Shackcloth J; Williams L; Farrell DJ
J Infect; 2004 Apr; 48(3):229-35. PubMed ID: 15001301
[TBL] [Abstract][Full Text] [Related]
4. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
Farrell DJ; Jenkins SG
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
[TBL] [Abstract][Full Text] [Related]
5. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.
Jenkins SG; Brown SD; Farrell DJ
Ann Clin Microbiol Antimicrob; 2008 Jan; 7():1. PubMed ID: 18190701
[TBL] [Abstract][Full Text] [Related]
6. Detection of macrolide resistance mechanisms in Streptococcus pneumoniae and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization.
Farrell DJ; Morrissey I; Bakker S; Felmingham D
J Antimicrob Chemother; 2001 Oct; 48(4):541-4. PubMed ID: 11581234
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study.
Brown SD; Farrell DJ; Morrissey I
J Clin Microbiol; 2004 Nov; 42(11):4980-7. PubMed ID: 15528684
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from North America.
Hoban DJ
J Chemother; 2002 Jul; 14 Suppl 3():25-30. PubMed ID: 12418558
[TBL] [Abstract][Full Text] [Related]
9. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
[TBL] [Abstract][Full Text] [Related]
10. Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae: results of two years of the PROTEKT surveillance study.
Schito GC; Marchese A; Elkharrat D; Farrell DJ;
J Chemother; 2004 Feb; 16(1):13-22. PubMed ID: 15077994
[TBL] [Abstract][Full Text] [Related]
11. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.
Bley C; van der Linden M; Reinert RR
Int J Antimicrob Agents; 2011 May; 37(5):425-31. PubMed ID: 21419605
[TBL] [Abstract][Full Text] [Related]
12. Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001.
Reinert RR; Lütticken R; Bryskier A; Al-Lahham A
Antimicrob Agents Chemother; 2003 Feb; 47(2):489-93. PubMed ID: 12543648
[TBL] [Abstract][Full Text] [Related]
13. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
Mazzariol A; Koncan R; Bahar G; Cornaglia G
J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000).
Mendes C; Marin ME; Quiñones F; Sifuentes-Osornio J; Siller CC; Castanheira M; Zoccoli CM; López H; Súcari A; Rossi F; Angulo GB; Segura AJ; Starling C; Mimica I; Felmingham D
Braz J Infect Dis; 2003 Feb; 7(1):44-61. PubMed ID: 12807691
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
Sunakawa K; Farrell DJ
Ann Clin Microbiol Antimicrob; 2007 Aug; 6():7. PubMed ID: 17697316
[TBL] [Abstract][Full Text] [Related]
16. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin.
Felmingham D; Reinert RR; Hirakata Y; Rodloff A
J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():25-37. PubMed ID: 12239226
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against community-acquired bacterial respiratory tract pathogens in the United States: findings from the PROTEKT US study, 2000-2001.
Stratton CW; Brown SD
Clin Ther; 2004 Apr; 26(4):522-30. PubMed ID: 15189749
[TBL] [Abstract][Full Text] [Related]
18. Characterization of erythromycin-resistant Streptococcus pneumoniae in Korea, and In Vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae.
Kim NJ; Park SJ; Choi SH; Lee MS; Choo EJ; Kwak YG; Woo JH; Ryu J; Jeong JY; Kim YS
Microb Drug Resist; 2005; 11(3):260-5. PubMed ID: 16201929
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000.
Cantón R; Loza E; Morosini MI; Baquero F
J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():9-24. PubMed ID: 12239225
[TBL] [Abstract][Full Text] [Related]
20. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004).
Farrell DJ; Couturier C; Hryniewicz W
Int J Antimicrob Agents; 2008 Mar; 31(3):245-9. PubMed ID: 18178388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
